Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.
Gallbladder Cancer (Oncology) - Drugs in Development, 2021
By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 1118
Gallbladder Cancer (Oncology) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Gallbladder Cancer - Drugs In Development, 2021, provides an overview of the Gallbladder....
Cervical Cancer (Oncology) - Drugs in Development, 2021
By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 2171
Cervical Cancer (Oncology) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Cervical Cancer - Drugs In Development, 2021, provides an overview of the Cervical....
Endometrial Cancer (Oncology) - Drugs in Development, 2021
By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 2259
Endometrial Cancer (Oncology) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Endometrial Cancer - Drugs In Development, 2021, provides an overview of the Endometrial....
Vaginal Cancer (Oncology) - Drugs in Development, 2021
By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 579
Vaginal Cancer (Oncology) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Vaginal Cancer - Drugs In Development, 2021, provides an overview of the Vaginal....
Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Drugs in Development, 2021
By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 63
Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Drugs in Development, 2021 Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) pipeline Target constitutes close to 14 molecules. Out....
